← Browse by Condition
Medical Condition

endometrial adenocarcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05112601 Phase 2
Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Enrollment
81 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →